Literature DB >> 11378681

The suitability of hepatocyte culture models to study various aspects of drug metabolism.

A K Nussler1, A Wang, P Neuhaus, J Fischer, J Yuan, L Liu, K Zeilinger, J Gerlach, P J Arnold, W Albrecht.   

Abstract

Since the liver is the main organ involved in the metabolism and the toxicity of xenobiotics, isolated rat hepatocytes have been increasingly used in recent years as a model to identify pharmacological and toxicological responses of drugs. However, it is generally recognised that isolated hepatocytes retain most of their functions only for a short period. For this reason, numerous models and techniques have been developed to study and improve the metabolic capacity of hepatocytes in vitro over an extended time period and in application for drug metabolism studies. In the present study, we compared four different cell culture models to fulfill these requirements and have therefore harvested hepatocytes and cultured them in different culture systems over two weeks. In order to prove certain advantages or disadvantages of each model, we compared the metabolic capacity, albumin secretion, the release of cytosolic and mitochondrial enzymes, as well as the capacity to metabolise diclofenac (DF). We found that rat hepatocytes in all studied culture models (except the Unisyn Bioreactor) were able to metabolise DF to the same extent as found in vivo. However, the concentration of metabolites was found to decrease with culture time using the monolayer although the DF metabolite level in the collagen Sandwich culture was higher than that of the monolayer culture. The 3D-membrane bioreactor preserved the metabolic capacity for a prolonged period of time. The concentrations of DF metabolites in the Unisyn hollow fiber bioreactor were below the detection limit, which corresponded to other parameters such as albumin secretion and cytochrome P450 activity, disqualifying this culture system clearly for the use of in vitro primary hepatocyte cultures. The other three systems all have their place in drug metabolism with different advantages. However, our studies clearly showed that hepatocytes cultured within a collagen sandwich or in the 3D-membrane bioreactor qualify to study various aspects of drug metabolisms over a long time period. Further studies are needed to prove if the later two culture models may really help to reduce animal testing.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11378681

Source DB:  PubMed          Journal:  ALTEX        ISSN: 1868-596X            Impact factor:   6.043


  4 in total

1.  Remodeling of Hepatocyte Mitochondrial Metabolism and De Novo Lipogenesis During the Embryonic-to-Neonatal Transition in Chickens.

Authors:  Chaitra Surugihalli; Linda S Farley; Ronique C Beckford; Boonyarit Kamkrathok; Hsiao-Ching Liu; Vaishna Muralidaran; Kruti Patel; Tom E Porter; Nishanth E Sunny
Journal:  Front Physiol       Date:  2022-04-21       Impact factor: 4.755

Review 2.  Considerations for Improving Metabolism Predictions for In Vitro to In Vivo Extrapolation.

Authors:  Marjory Moreau; Pankajini Mallick; Marci Smeltz; Saad Haider; Chantel I Nicolas; Salil N Pendse; Jeremy A Leonard; Matthew W Linakis; Patrick D McMullen; Rebecca A Clewell; Harvey J Clewell; Miyoung Yoon
Journal:  Front Toxicol       Date:  2022-04-29

Review 3.  3D Cultivation Techniques for Primary Human Hepatocytes.

Authors:  Anastasia Bachmann; Matthias Moll; Eric Gottwald; Cordula Nies; Roman Zantl; Helga Wagner; Britta Burkhardt; Juan J Martínez Sánchez; Ruth Ladurner; Wolfgang Thasler; Georg Damm; Andreas K Nussler
Journal:  Microarrays (Basel)       Date:  2015-02-16

4.  Tethered primary hepatocyte spheroids on polystyrene multi-well plates for high-throughput drug safety testing.

Authors:  Farah Tasnim; Nisha Hari Singh; Elijah Keng Foo Tan; Jiangwa Xing; Huan Li; Sebastien Hissette; Sravanthy Manesh; Justina Fulwood; Kapish Gupta; Chan Way Ng; Shuoyu Xu; Jeffrey Hill; Hanry Yu
Journal:  Sci Rep       Date:  2020-03-16       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.